Shenzhen - Delayed Quote CNY

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ)

104.95
+0.96
+(0.92%)
At close: May 20 at 3:04:21 PM GMT+8
Loading Chart for 000661.SZ
  • Previous Close 103.99
  • Open 97.32
  • Bid 104.97 x --
  • Ask 104.98 x --
  • Day's Range 104.22 - 107.75
  • 52 Week Range 77.50 - 125.78
  • Volume 10,233,259
  • Avg. Volume 6,200,288
  • Market Cap (intraday) 42.813B
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) 19.22
  • EPS (TTM) 5.46
  • Earnings Date Apr 21, 2025
  • Forward Dividend & Yield 4.50 (4.82%)
  • Ex-Dividend Date Apr 18, 2024
  • 1y Target Est 107.17

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicines, and other pharmaceutical products; and antibody and other chemical drugs. It also develops real estate properties. Changchun High-Tech Industry (Group) Co., Ltd. was founded in 1993 and is based in Changchun, China.

ccht.jl.cn

11,547

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000661.SZ

View More

Performance Overview: 000661.SZ

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000661.SZ
5.54%
SSE Composite Index (000001.SS)
0.86%

1-Year Return

000661.SZ
10.19%
SSE Composite Index (000001.SS)
6.60%

3-Year Return

000661.SZ
30.86%
SSE Composite Index (000001.SS)
7.43%

5-Year Return

000661.SZ
66.18%
SSE Composite Index (000001.SS)
17.23%

Compare To: 000661.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000661.SZ

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    42.81B

  • Enterprise Value

    38.51B

  • Trailing P/E

    19.22

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.18

  • Price/Book (mrq)

    1.82

  • Enterprise Value/Revenue

    2.90

  • Enterprise Value/EBITDA

    14.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.54%

  • Return on Assets (ttm)

    6.07%

  • Return on Equity (ttm)

    8.72%

  • Revenue (ttm)

    13.29B

  • Net Income Avi to Common (ttm)

    2.2B

  • Diluted EPS (ttm)

    5.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.83B

  • Total Debt/Equity (mrq)

    5.75%

  • Levered Free Cash Flow (ttm)

    143.12M

Research Analysis: 000661.SZ

View More

Company Insights: 000661.SZ

Research Reports: 000661.SZ

View More

People Also Watch